Precigen, Inc. (NASDAQ:PGEN)
Stock Price:
$1.86
-0.075
(-3.89%)
Updated
Feb 7, 2023 08:59 PM GMT+0000
Overview
Financials
Statistics
Profile
Chart
| Market Cap | 465.62M |
|---|---|
| Revenue | 75.88M |
| Gross Profit | 40.46M |
| Shares Out | 251.01M |
| EPS (ttm) | 0.1273 |
| PE Ratio | 19.0284 |
| Forward PE | -3.7295 |
| Dividend Rate (ttm) | 0.0000 |
| Dividend Yield | 0.0000 |
| Trading Day | Feb 7 |
|---|---|
| Last Price | $1.86 |
| Previous Close | $1.93 |
| Change ($) | -0.075 |
| Change (%) | -3.89% |
| Day's Open | 1.96 |
| Day's Range | Market Closed |
| Day's Volume | 2.35M |
| 52 Week Range | 1.12 - 2.9 |
About Precigen, Inc.
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. The Company's technologies enable to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and commercialization.
News
No news found.Quick info
Country
United States
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Employees
484
CEO
Helen Sabzevari
Address
20374 Seneca Meadows Parkway
Germantown
Maryland
20876
Germantown
Maryland
20876
Phone
13015569900
Website
precigen.com
Ticker Symbol
PGEN
Exchange
NASDAQ Stock Exchange
Reporting Currency
USD
Precigen, Inc. income statements (2022) (USD)
| August 2022 | August 2022 | May 2022 | March 2022 | |
|---|---|---|---|---|
| Total Revenue | 2.91M | 2.91M | 32.02M | 24.22M |
| Cost of Revenue | 1.81M | 1.81M | 17.10M | 14.93M |
| Gross Profit | 1.10M | 1.10M | 14.92M | 9.30M |
| Research & Development | 11.95M | 11.95M | 12.76M | 13.02M |
| Selling General & Admin | 12.67M | 12.67M | 19.58M | 16.76M |
| Operating Expense | 26.44M | 26.44M | 49.44M | 44.71M |
| Operating Income | -23.52M | -23.52M | -17.42M | -20.49M |
| Other Income Expense Net | 0 | 0 | 0 | 0 |
| EBIT | -23.52M | -23.52M | -17.42M | -20.49M |
| Interest Income | 2.03M | 2.03M | 1.64M | 4.57M |
| Pretax Income | -26.15M | -26.15M | -19.31M | -25.02M |
| Income Tax | -89K | -89K | -58K | 13K |
| Minority Interest | 0 | 0 | 0 | 0 |
| Net Income | -17.64M | -17.64M | -19.25M | -25.03M |
| Net Income Basic | -17.64M | -17.64M | -19.25M | -25.03M |
Precigen, Inc. income statements (2021) (USD)
| November 2021 | August 2021 | May 2021 | March 2021 | |
|---|---|---|---|---|
| Total Revenue | 21.56M | 33.58M | 24.51M | 19.33M |
| Cost of Revenue | 15.45M | 15.03M | 12.98M | 13.79M |
| Gross Profit | 6.11M | 18.55M | 11.54M | 5.54M |
| Research & Development | 12.92M | 13.68M | 10.52M | -3.61M |
| Selling General & Admin | 18.66M | 20M | 18.70M | 27.65M |
| Operating Expense | 47.03M | 48.71M | 42.20M | 37.84M |
| Operating Income | -25.47M | -15.13M | -17.69M | -18.51M |
| Other Income Expense Net | 0 | 0 | 0 | 0 |
| EBIT | -25.47M | -15.13M | -17.69M | -18.51M |
| Interest Income | 4.30M | 4.26M | 4.15M | 4.14M |
| Pretax Income | -29.89M | -20.12M | -21.9M | -0.92M |
| Income Tax | -61K | -60K | -52K | 48K |
| Minority Interest | 0 | 0 | 0 | 0 |
| Net Income | -29.76M | -20.05M | -17.32M | -41.66M |
| Net Income Basic | -29.76M | -20.05M | -17.32M | -41.66M |
Precigen, Inc. income statements (2020) (USD)
| November 2020 | June 2020 | March 2020 | March 2020 | |
|---|---|---|---|---|
| Total Revenue | 23.58M | 30.42M | 29.84M | 29.84M |
| Cost of Revenue | 13.19M | 14.91M | 13.63M | 13.63M |
| Gross Profit | 10.40M | 15.51M | 16.21M | 16.21M |
| Research & Development | 12.15M | 14.21M | 18.89M | 18.89M |
| Selling General & Admin | 22.30M | 18.74M | 23.02M | 23.02M |
| Operating Expense | 48.16M | 47.86M | 55.53M | 55.53M |
| Operating Income | -24.58M | -17.43M | -25.7M | -25.7M |
| Other Income Expense Net | 0 | -26.04M | -4.21M | -4.21M |
| EBIT | -24.58M | -17.43M | -25.7M | -25.7M |
| Interest Income | 4.07M | 4.59M | 4.59M | 4.59M |
| Pretax Income | -29.56M | -43.47M | -29.9M | -29.9M |
| Income Tax | -50K | -120K | 40K | 40K |
| Minority Interest | 0 | 0 | 0 | 0 |
| Net Income | -29.51M | -43.35M | -56.67M | -56.67M |
| Net Income Basic | -29.51M | -43.35M | -56.67M | -56.67M |
Precigen, Inc. income statements (2019) (USD)
| December 2019 | September 2019 | June 2019 | March 2019 | |
|---|---|---|---|---|
| Total Revenue | 17M | 23.04M | 35.99M | 23.34M |
| Cost of Revenue | 15.41M | 14.81M | 17.39M | 15.38M |
| Gross Profit | 1.59M | 8.23M | 18.59M | 7.95M |
| Research & Development | 21.04M | 31.48M | 34.52M | 33.06M |
| Selling General & Admin | 28.36M | 24.74M | 21.48M | 33.59M |
| Operating Expense | 64.80M | 71.03M | 73.40M | 82.04M |
| Operating Income | -47.8M | -47.99M | -37.41M | -58.7M |
| Other Income Expense Net | -26.6M | -6.16M | -2.05M | -4.01M |
| EBIT | -47.8M | -47.99M | -37.41M | -58.7M |
| Interest Income | 4.54M | 4.47M | 4.36M | 4.31M |
| Pretax Income | -74.4M | -54.15M | -39.46M | -62.71M |
| Income Tax | -0.91M | -512K | -525K | -578K |
| Minority Interest | 0 | 0 | -165K | -1.43M |
| Net Income | -169.22M | -53.63M | -38.77M | -60.71M |
| Net Income Basic | -169.22M | -53.63M | -38.77M | -60.71M |
Precigen, Inc. income statements (2018) (USD)
| December 2018 | September 2018 | June 2018 | March 2018 | |
|---|---|---|---|---|
| Total Revenue | 43.19M | 32.45M | 45.28M | 43.84M |
| Cost of Revenue | 14.11M | 15.33M | 18.53M | 15.31M |
| Gross Profit | 29.07M | 17.12M | 26.74M | 28.53M |
| Research & Development | 52.51M | 36.19M | 42.05M | 37.27M |
| Selling General & Admin | 24.94M | 38.71M | 34.43M | 39.74M |
| Operating Expense | 91.56M | 90.22M | 95.01M | 92.32M |
| Operating Income | -48.38M | -57.77M | -49.74M | -48.47M |
| Other Income Expense Net | -295.34M | -15.3M | -18.22M | 1.16M |
| EBIT | -48.38M | -57.77M | -49.74M | -48.47M |
| Interest Income | 4.29M | 4M | 142K | 99K |
| Pretax Income | -343.72M | -73.07M | -67.96M | -47.32M |
| Income Tax | -1.99M | -14.32M | -1.13M | -4.09M |
| Minority Interest | -1.26M | -1.42M | -1.45M | -1.24M |
| Net Income | -340.47M | -57.32M | -65.38M | -41.99M |
| Net Income Basic | -340.47M | -57.32M | -65.38M | -41.99M |
Precigen, Inc. income statements (2017) (USD)
| December 2017 | September 2017 | June 2017 | |
|---|---|---|---|
| Total Revenue | 77.03M | 46.02M | 54.43M |
| Cost of Revenue | 15.36M | 15.01M | 16.85M |
| Gross Profit | 61.67M | 31M | 37.58M |
| Research & Development | 38.54M | 36.47M | 34.01M |
| Selling General & Admin | 31.01M | 39.18M | 38.50M |
| Operating Expense | 84.91M | 90.67M | 89.36M |
| Operating Income | -7.88M | -44.65M | -34.93M |
| Other Income Expense Net | -26.78M | 3M | 14.45M |
| EBIT | -7.88M | -44.65M | -34.93M |
| Interest Income | 113K | 138K | 181K |
| Pretax Income | -34.66M | -41.65M | -20.48M |
| Income Tax | -716K | -818K | -813K |
| Minority Interest | -6.68M | -1.15M | -1M |
| Net Income | -27.27M | -39.69M | -18.66M |
| Net Income Basic | -27.27M | -39.69M | -18.66M |
Precigen, Inc. balance sheet (2022) (USD)
| August 2022 | August 2022 | May 2022 | March 2022 | |
|---|---|---|---|---|
| Current Cash | 115.30M | 115.30M | 112.14M | 115.16M |
| Receivables | 1.87M | 1.87M | 24.87M | 21.47M |
| Inventory | 224K | 224K | 12.73M | 13.26M |
| Current Assets | 164.62M | 164.62M | 154.94M | 156.63M |
| Other Current Assets | 2.65M | 2.65M | 5.20M | 6.74M |
| Short Term Investments | 2.65M | 2.65M | 5.20M | 6.74M |
| Long Term Investments | 156.61M | 156.61M | 180.63M | 203.23M |
| Property/Plant Equipment | 7.73M | 7.73M | 33.58M | 34.32M |
| Good Will | N.A | N.A | N.A | N.A |
| Intangible Assets | 45.93M | 45.93M | 51.43M | 54.12M |
| Tangible Assets (Net) | -27.14M | -27.14M | -31.2M | -0.92M |
| Other Assets | 45.26M | 45.26M | 1.13M | 1.19M |
| Total Assets | 321.22M | 321.22M | 335.57M | 359.86M |
| Accounts Payable | 2.67M | 2.67M | 4.42M | 5.41M |
| Other Current Liabilities | 27.23M | 27.23M | 20.83M | 28.84M |
| Total Current Liabilities | 29.90M | 29.90M | 25.60M | 34.65M |
| Total Liabilities | 265.57M | 265.57M | 261.73M | 252.51M |
| Long Term Debt | 198.67M | 198.67M | 201.11M | 182.75M |
| Current Long Term Debt | 0 | 0 | 355K | 402K |
| Minority Interest | 0 | 0 | 0 | 0 |
| Common Stock | 200.46M | 200.46M | 199.63M | 199.34M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Retained Earnings | -1.93B | -1.93B | -1.92B | -1.92B |
| Capital Surplus | N.A | N.A | N.A | N.A |
| Shareholder Equity | 55.65M | 55.65M | 73.84M | 107.35M |
| Other Liabilities | N.A | N.A | N.A | N.A |
Precigen, Inc. balance sheet (2021) (USD)
| November 2021 | August 2021 | May 2021 | March 2021 | |
|---|---|---|---|---|
| Current Cash | 114.41M | 115.11M | 105.69M | 100.12M |
| Receivables | 21.08M | 26.67M | 21.36M | 20.43M |
| Inventory | 9.94M | 11.41M | 10.64M | 11.36M |
| Current Assets | 153.09M | 156.69M | 144.12M | 148.95M |
| Other Current Assets | 7.66M | 3.48M | 6.43M | 7.19M |
| Short Term Investments | 7.66M | 3.48M | 6.43M | 7.19M |
| Long Term Investments | 223.81M | 245.89M | 262.87M | 165.64M |
| Property/Plant Equipment | 32.76M | 32.75M | 33.72M | 34.92M |
| Good Will | N.A | N.A | N.A | N.A |
| Intangible Assets | 56.91M | 59.94M | 61.23M | 65.40M |
| Tangible Assets (Net) | 20.13M | 44.98M | 59.33M | -52.59M |
| Other Assets | 1.24M | 1.33M | 1.43M | 1.60M |
| Total Assets | 376.90M | 402.57M | 406.98M | 314.59M |
| Accounts Payable | 3.62M | 4.94M | 4.30M | 4.60M |
| Other Current Liabilities | 25.01M | 23.58M | 20.59M | 37.17M |
| Total Current Liabilities | 28.99M | 28.87M | 25.24M | 42.13M |
| Total Liabilities | 245.65M | 243.38M | 232.19M | 247.41M |
| Long Term Debt | 179.82M | 176.92M | 174.16M | 171.52M |
| Current Long Term Debt | 355K | 356K | 359K | 360K |
| Minority Interest | 0 | 0 | 0 | 0 |
| Common Stock | 199.18M | 199.02M | 193.50M | 178.33M |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Retained Earnings | -1.89B | -1.86B | -1.84B | -1.82B |
| Capital Surplus | N.A | N.A | N.A | N.A |
| Shareholder Equity | 131.25M | 159.20M | 174.80M | 67.17M |
| Other Liabilities | N.A | N.A | N.A | N.A |
Precigen, Inc. balance sheet (2020) (USD)
| November 2020 | June 2020 | March 2020 | March 2020 | |
|---|---|---|---|---|
| Current Cash | 113.10M | 46.71M | 37.84M | 37.84M |
| Receivables | 19.36M | 23.63M | 19.38M | 19.38M |
| Inventory | 10.35M | 12.73M | 14.64M | 14.64M |
| Current Assets | 151.12M | 173M | 189.38M | 189.38M |
| Other Current Assets | 8.31M | 3.27M | 5.95M | 5.95M |
| Short Term Investments | 8.31M | 86.29M | 111.33M | 111.33M |
| Long Term Investments | 185.07M | 1.28M | 1.52M | 1.52M |
| Property/Plant Equipment | 44.69M | 67.64M | 83.66M | 83.66M |
| Good Will | N.A | N.A | N.A | N.A |
| Intangible Assets | 65.02M | 64.76M | 65.49M | 65.49M |
| Tangible Assets (Net) | -60.7M | -166.14M | -146.14M | -146.14M |
| Other Assets | 1.50M | 0.92M | 0.92M | 0.92M |
| Total Assets | 336.19M | 361.72M | 404.67M | 404.67M |
| Accounts Payable | 4.23M | 3.83M | 4.92M | 4.92M |
| Other Current Liabilities | 26.01M | 23.65M | 28.32M | 28.32M |
| Total Current Liabilities | 30.66M | 64.10M | 70.64M | 70.64M |
| Total Liabilities | 277.63M | 312.17M | 317.44M | 317.44M |
| Long Term Debt | 193.80M | 212.42M | 211.14M | 211.14M |
| Current Long Term Debt | 421K | 32.11M | 31.89M | 31.89M |
| Minority Interest | 0 | 0 | 0 | 0 |
| Common Stock | 1.84B | 172.29M | 170.66M | 170.66M |
| Treasury Stock | 0 | N.A | N.A | N.A |
| Retained Earnings | -1.78B | -1.75B | -1.71B | -1.71B |
| Capital Surplus | N.A | 1.80B | 1.80B | 1.80B |
| Shareholder Equity | 58.55M | 49.54M | 87.23M | 87.23M |
| Other Liabilities | N.A | N.A | N.A | N.A |
Precigen, Inc. balance sheet (2019) (USD)
| December 2019 | September 2019 | June 2019 | March 2019 | |
|---|---|---|---|---|
| Current Cash | 65.79M | 44.43M | 58.16M | 106.54M |
| Receivables | 21.25M | 20.41M | 24.50M | 19.86M |
| Inventory | 16.10M | 17.30M | 18.19M | 19.90M |
| Current Assets | 234.64M | 157.33M | 183.16M | 232.18M |
| Other Current Assets | 117.27M | 9.03M | 4.71M | 5.58M |
| Short Term Investments | 9.26M | 61.61M | 67.64M | 75.28M |
| Long Term Investments | 1.88M | 24.80M | 40.40M | 20.05M |
| Property/Plant Equipment | 86.20M | 165.92M | 161.96M | 179.46M |
| Good Will | N.A | N.A | N.A | N.A |
| Intangible Assets | 68.35M | 107.14M | 112.53M | 125.87M |
| Tangible Assets (Net) | -163.06M | -225.33M | -181.9M | -163.34M |
| Other Assets | 0.94M | 1.77M | 7.23M | 1.56M |
| Total Assets | 471.01M | 604.91M | 655.19M | 709.86M |
| Accounts Payable | 5.97M | 7.44M | 8.64M | 14.77M |
| Other Current Liabilities | 79.17M | 36.29M | 37.33M | 39.03M |
| Total Current Liabilities | 122.91M | 81.96M | 51.63M | 59.42M |
| Total Liabilities | 399.30M | 376.48M | 375.97M | 375.04M |
| Long Term Debt | 210.17M | 222.22M | 251.24M | 254.20M |
| Current Long Term Debt | 31.67M | 31.43M | 468K | 564K |
| Minority Interest | 0 | 0 | -165K | -1.43M |
| Common Stock | 163.27M | 162.51M | 161.92M | 160.62M |
| Treasury Stock | N.A | N.A | N.A | N.A |
| Retained Earnings | -1.65B | -1.48B | -1.43B | -1.39B |
| Capital Surplus | 1.75B | 1.75B | 1.74B | 1.73B |
| Shareholder Equity | 71.71M | 228.42M | 279.22M | 313.03M |
| Other Liabilities | N.A | N.A | N.A | N.A |
Precigen, Inc. balance sheet (2018) (USD)
| December 2018 | September 2018 | June 2018 | March 2018 | |
|---|---|---|---|---|
| Current Cash | 109.76M | 89.40M | 85.46M | 126.92M |
| Receivables | 25.32M | 18.16M | 22.62M | 17.70M |
| Inventory | 21.45M | 18.29M | 20.07M | 20.27M |
| Current Assets | 285.48M | 310.47M | 147.81M | 187.55M |
| Other Current Assets | 6.13M | 7.59M | 5.80M | 6.07M |
| Short Term Investments | 120.07M | 164.88M | 2.66M | 3.57M |
| Long Term Investments | 21.28M | 180.78M | 184.27M | 198.68M |
| Property/Plant Equipment | 128.87M | 122.71M | 119.41M | 119.24M |
| Good Will | N.A | N.A | N.A | N.A |
| Intangible Assets | 129.29M | 213.24M | 218.84M | 231.88M |
| Tangible Assets (Net) | -111.65M | -43.44M | -34.18M | -46.35M |
| Other Assets | 1.67M | 1.94M | 3.16M | 3.57M |
| Total Assets | 721.63M | 0.98B | 825.15M | 895.67M |
| Accounts Payable | 13.68M | 8.67M | 8.56M | 7.99M |
| Other Current Liabilities | 46.86M | 82.92M | 73.63M | 78.04M |
| Total Current Liabilities | 61.56M | 92.33M | 83.25M | 86.85M |
| Total Liabilities | 342.91M | 424.97M | 258.01M | 324.24M |
| Long Term Debt | 211.24M | 183.13M | 7.27M | 7.43M |
| Current Long Term Debt | 559K | 546K | 489K | 501K |
| Minority Interest | -1.26M | -1.42M | -1.45M | -1.24M |
| Common Stock | 160.02M | 137.14M | 129.42M | 129.24M |
| Treasury Stock | N.A | N.A | N.A | N.A |
| Retained Earnings | -1.33B | -0.99B | -0.93B | -0.93B |
| Capital Surplus | 1.72B | 1.55B | 1.50B | 1.49B |
| Shareholder Equity | 362.86M | 539.40M | 549.75M | 553.11M |
| Other Liabilities | N.A | N.A | N.A | N.A |
Precigen, Inc. balance sheet (2017) (USD)
| December 2017 | September 2017 | June 2017 | |
|---|---|---|---|
| Current Cash | 75.10M | 71.20M | 71.35M |
| Receivables | 37.69M | 36M | 41.56M |
| Inventory | 20.49M | 17.73M | 19.15M |
| Current Assets | 154.05M | 179.74M | 234.12M |
| Other Current Assets | 7.06M | 8.05M | 7.18M |
| Short Term Investments | 11.56M | 44.50M | 92.80M |
| Long Term Investments | 190.40M | 198.08M | 190.55M |
| Property/Plant Equipment | 112.67M | 102.88M | 92.88M |
| Good Will | N.A | N.A | N.A |
| Intangible Assets | 232.88M | 240.90M | 240.36M |
| Tangible Assets (Net) | -59.73M | -92.8M | -65.63M |
| Other Assets | 3.56M | 9.84M | 11.15M |
| Total Assets | 846.85M | 898.26M | 0.93B |
| Accounts Payable | 9.01M | 8.67M | 8.97M |
| Other Current Liabilities | 70.42M | 78.46M | 86M |
| Total Current Liabilities | 80.17M | 87.80M | 95.69M |
| Total Liabilities | 300.31M | 345.08M | 362.44M |
| Long Term Debt | 7.54M | 7.67M | 7.68M |
| Current Long Term Debt | 502K | 439K | 434K |
| Minority Interest | -6.68M | -1.15M | -1M |
| Common Stock | 122.09M | 120.62M | 120.40M |
| Treasury Stock | N.A | N.A | N.A |
| Retained Earnings | -847.82M | -820.55M | -780.87M |
| Capital Surplus | 1.40B | 1.37B | 1.36B |
| Shareholder Equity | 533.63M | 533.61M | 550.87M |
| Other Liabilities | N.A | N.A | N.A |
Precigen, Inc. cash flow (2022) (USD)
| November 2022 | August 2022 | |
|---|---|---|
| Net Income | 87.38M | -17.64M |
| Depreciation | 2.53M | 3.23M |
| Changes in Receivables | 2.45M | 1.87M |
| Changes in Inventories | 219K | 224K |
| Cash Change | 71.33M | 115.30M |
| Cash Flow | -23.81M | -7.05M |
| Capital Expenditures | -1.57M | -1.72M |
| Investments | N.A | N.A |
| Investing Activity (other) | N.A | N.A |
| Total Investing Cash Flows | 181.86M | 16.57M |
| Dividends Paid | N.A | N.A |
| Net Borrowings | 4.38M | 80.72M |
| Other Financing Cash Flows | N.A | N.A |
| Cash Flow Financing | -115.73M | -113K |
| Exchange Rate Effect | N.A | N.A |
Precigen, Inc. cash flow (2021) (USD)
| November 2021 | |
|---|---|
| Net Income | -29.76M |
| Depreciation | 3.40M |
| Changes in Receivables | 21.08M |
| Changes in Inventories | 9.94M |
| Cash Change | 114.41M |
| Cash Flow | -17.02M |
| Capital Expenditures | -2.27M |
| Investments | N.A |
| Investing Activity (other) | N.A |
| Total Investing Cash Flows | 22.01M |
| Dividends Paid | N.A |
| Net Borrowings | 58.10M |
| Other Financing Cash Flows | N.A |
| Cash Flow Financing | 234K |
| Exchange Rate Effect | N.A |
Precigen, Inc. cash flow (2020) (USD)
| November 2020 | June 2020 | March 2020 | |
|---|---|---|---|
| Net Income | -29.51M | -43.35M | -56.67M |
| Depreciation | 13.70M | 4.78M | 4.81M |
| Changes in Receivables | -4.64M | -4.26M | 1.87M |
| Changes in Inventories | -2.38M | 1.92M | 1.20M |
| Cash Change | -19.91M | 8.88M | -30.18M |
| Cash Flow | -60.55M | -13.67M | -27.69M |
| Capital Expenditures | -6.06M | -1.88M | -3.15M |
| Investments | N.A | 25.01M | -101.27M |
| Investing Activity (other) | N.A | N.A | N.A |
| Total Investing Cash Flows | -12.41M | 23.97M | -36.55M |
| Dividends Paid | N.A | N.A | N.A |
| Net Borrowings | 72.81M | -1.46M | -0.9M |
| Other Financing Cash Flows | N.A | N.A | N.A |
| Cash Flow Financing | 32.78M | -1.4M | 34.10M |
| Exchange Rate Effect | N.A | -20K | -39K |
Precigen, Inc. cash flow (2019) (USD)
| December 2019 | September 2019 | June 2019 | March 2019 | |
|---|---|---|---|---|
| Net Income | -169.22M | -53.63M | -38.77M | -60.71M |
| Depreciation | 6.19M | 6.02M | 6.11M | 6.58M |
| Changes in Receivables | -837K | 4.08M | -4.64M | 5.47M |
| Changes in Inventories | -675K | 1.68M | 1.72M | 1.38M |
| Cash Change | 23.60M | -13.75M | -48.38M | -3.22M |
| Cash Flow | -34.83M | -23.47M | -33.4M | -43.23M |
| Capital Expenditures | -4.68M | -7.78M | -13.9M | -11.52M |
| Investments | 58.87M | 22.59M | 45.17M | 45.42M |
| Investing Activity (other) | 7.24M | N.A | -7.24M | N.A |
| Total Investing Cash Flows | 54.51M | 13.78M | -15.03M | 33.59M |
| Dividends Paid | N.A | N.A | N.A | N.A |
| Net Borrowings | 3.88M | -3.64M | -33K | 9K |
| Other Financing Cash Flows | N.A | N.A | N.A | N.A |
| Cash Flow Financing | 3.88M | -3.64M | -33K | 6.93M |
| Exchange Rate Effect | 33K | -425K | 86K | -504K |
Precigen, Inc. cash flow (2018) (USD)
| December 2018 | September 2018 | June 2018 | March 2018 | |
|---|---|---|---|---|
| Net Income | -340.47M | -57.32M | -65.38M | -41.99M |
| Depreciation | 7.93M | 8.30M | 8.50M | 8.38M |
| Changes in Receivables | -7.16M | 4.46M | -4.92M | 19.99M |
| Changes in Inventories | -3.06M | 2.15M | 201K | 231K |
| Cash Change | 20.35M | 3.94M | -41.48M | 51.83M |
| Cash Flow | -37.36M | -28.82M | -28.17M | -29.89M |
| Capital Expenditures | -11.23M | -8.77M | -10.82M | -10.77M |
| Investments | 45M | -163.63M | 141K | 6M |
| Investing Activity (other) | N.A | N.A | N.A | N.A |
| Total Investing Cash Flows | 30.74M | -161.03M | -13.46M | -7.46M |
| Dividends Paid | N.A | N.A | N.A | N.A |
| Net Borrowings | 25.99M | 193.42M | 112K | -52K |
| Other Financing Cash Flows | N.A | N.A | N.A | N.A |
| Cash Flow Financing | 27.25M | 193.60M | 684K | 88.26M |
| Exchange Rate Effect | -283K | 197K | -533K | 0.91M |
Precigen, Inc. cash flow (2017) (USD)
| December 2017 | September 2017 | June 2017 | |
|---|---|---|---|
| Net Income | -27.27M | -39.69M | -18.66M |
| Depreciation | 8.26M | 7.99M | 7.49M |
| Changes in Receivables | -1.69M | 5.56M | -76K |
| Changes in Inventories | -2.76M | 1.42M | -58K |
| Cash Change | 3.90M | -144K | -5.49M |
| Cash Flow | -33.88M | -22.01M | -23.56M |
| Capital Expenditures | -13.99M | -14.41M | -11.92M |
| Investments | 47.72M | 38.82M | 43.24M |
| Investing Activity (other) | 1.16M | -1.16M | N.A |
| Total Investing Cash Flows | 23.91M | 28.14M | 17.73M |
| Dividends Paid | N.A | N.A | N.A |
| Net Borrowings | -95K | -184K | -95K |
| Other Financing Cash Flows | N.A | -6.69M | N.A |
| Cash Flow Financing | 13.70M | -6.68M | 408K |
| Exchange Rate Effect | 157K | 413K | -69K |
Precigen, Inc. dividends (USD)
Total Valuation
Precigen Inc has a market cap or net worth of $465.62 million. The enterprise value is $495.19 million.
Market Cap
465.62M
Enterprise Value
495.19M
Important Dates
Earnings Date
Feb 28, 2023
Ex-Dividend Date
n.a
Share Statistics
Precigen Inc has 251.01 million shares outstanding.
Shares Outstanding
251.01M
Float
n.a
Valuation Ratios
The trailing PE ratio is 19.0284 and the forward PE ratio is -3.7295. Precigen Inc's PEG ratio is 0.1553.
PE Ratio
19.0284
Forward PE
-3.7295
PS Ratio
6.3800
PB Ratio
3.4000
PEG Ratio
0.1553
Stock Price Statistics
The stock price has increased by 0.2697%. The beta is 1.7958, so Precigen Inc's price volatility has been higher than the market average.
Beta (1Y)
1.7958
52-Week Price Change
+0.2697%
50-Day Moving Average
1.68
200-Day Moving Average
1.92
Average Volume (30 Days)
2.89M
Income Statement
In the last 12 months, Precigen Inc had revenue of $75.88 million and earned $40.46 million in profits. Earnings per share was $0.1273.
Revenue
75.88M
Gross Profit
40.46M
EBITDA
-55.82M
Earnings per Share
0.1273
About
Ticker Symbol
PGEN
Reporting Currency
USD
Key Executives
Krishnan Suma
SVP--Regulatory Affairs
Lehr Donald P.
Chief Legal Officer
LIFFMAN JOEL D
SVP, Finance
Krishnan Krish S
Chief Operating Officer
Last Andrew J.
Chief Operating Officer
INTREXON CORP
SVP, Consumer Sector
Cratsenburg Ena Chan
SVP, Consumer Sector
Bobo Jack A
SVP, Chief Communications Off.
Webster Darryl
SVP--Intellectual Property
Kasser Thomas R.
SVP--Food Sector
Broder Samuel
EVP-Scientific & Pub. Affairs